瘢痕疙瘩治疗市场报告：2030 年趋势、预测与竞争分析

瘢痕疙瘩治疗的趋势和预测

预计到 2030 年，全球瘢痕疙瘩治疗市场将达到约 44.3 亿美元，2024 年至 2030 年复合年增长率为 3.0%。该市场的主要驱动力是烧烫伤和机动车事故的增加、瘢痕疙瘩治疗方法的发展以及对整容手术的接受度不断提高。全球瘢痕疙瘩治疗市场的未来看起来充满希望，医院、皮肤科诊所和门诊手术中心（ASCS）市场充满机会。

瘢痕疙瘩治疗市场洞察

Lucintel 预计病灶内皮质类固醇注射将在预测期内达到最高成长。

预计北美地区在预测期内将出现最高的成长。

常问问题

Q.1瘢痕疙瘩治疗的市场规模有多大？

A1. 到 2030 年，全球瘢痕疙瘩治疗市场预计将达到 44.3 亿美元。

Q.2瘢痕疙瘩治疗市场的成长预测是多少？

A2. 2024年至2030年，全球瘢痕疙瘩治疗市场预计将以3.0%的复合年增长率成长。

Q.3 影响瘢痕疙瘩治疗市场成长的关键因素有哪些：

A3. 该市场的主要驱动力是烧烫伤和机动车事故的增加、瘢痕疙瘩治疗方法的发展以及整容手术的接受度不断提高。

Q4.市场的主要细分市场是：

A4.瘢痕疙瘩治疗市场的前景看好，医院、皮肤科诊所和门诊手术中心（ASCS）市场都有机会。

Q5.市场的主要企业是：

A5. 主要的瘢痕疙瘩治疗公司如下。

• Novartis
• Sensus Healthcare
• RXi Pharmaceuticals
• Sonoma Pharmaceuticals
• Perrigo Company
• Bristol-Myers Squibb Company
• Pacific World Corporation
• Valeant Pharmaceuticals International
• Revitol Corporation
• Avita Medical Limited

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计病灶内皮质类固醇注射将在预测期内出现最高增长。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 预计北美在预测期内将经历最高的成长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球瘢痕疙瘩治疗市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球瘢痕疙瘩治疗市场趋势（2018-2023）与预测（2024-2030）
• 按治疗分類的全球瘢痕疙瘩治疗市场
  • 闭塞绷带
  • 压迫疗法
  • 冷冻手术
  • 切除
  • 放射治疗
  • 雷射治疗
  • 干扰素治疗
  • 病灶内注射皮质类固醇
  • 其他的
• 按最终用途行业分類的全球瘢痕疙瘩治疗市场
  • 医院
  • 皮肤科诊所
  • 日间手术中心 (ASC)
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 全球瘢痕疙瘩治疗市场（按地区）
• 北美瘢痕疙瘩治疗市场
• 欧洲瘢痕疙瘩治疗市场
• 亚太地区瘢痕疙瘩治疗市场
• 其他地区瘢痕疙瘩治疗市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球瘢痕疙瘩治疗市场按治疗方式的成长机会
  • 全球瘢痕疙瘩治疗市场最终用途产业的成长机会
  • 按地区分類的全球瘢痕疙瘩治疗市场成长机会
• 全球瘢痕疙瘩治疗市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球瘢痕疙瘩治疗市场的产能
  • 全球瘢痕疙瘩治疗市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Novartis
• Sensus Healthcare
• RXi Pharmaceuticals
• Sonoma Pharmaceuticals
• Perrigo Company
• Bristol-Myers Squibb Company
• Pacific World Corporation
• Valeant Pharmaceuticals International
• Revitol Corporation
• Avita Medical Limited

Keloid Treatment Trends and Forecast

The future of the global keloid treatment market looks promising with opportunities in the hospitals, dermatology clinics, and ambulatory surgical centers (ASCS) markets. The global keloid treatment market is expected to reach an estimated $4.43 billion by 2030 with a CAGR of 3.0% from 2024 to 2030. The major drivers for this market are rise in burn cases and auto accidents, developments in keloid treatment methods, and growing acceptance of cosmetic surgery.

A more than 150-page report is developed to help in your business decisions.

Keloid Treatment by Segment

The study includes a forecast for the global keloid treatment by treatment, end use industry, and region.

Keloid Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Occlusive Dressing
• Compression Therapy
• Cryosurgery
• Excision
• Radiation Therapy
• Laser Therapy
• Interferon Therapy
• Intralesional Corticosteroid Injections
• Others

Keloid Treatment Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Dermatology Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

Keloid Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Keloid Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies keloid treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the keloid treatment companies profiled in this report include-

• Novartis
• Sensus Healthcare
• Rxi Pharmaceuticals
• Sonoma Pharmaceuticals
• Perrigo Company
• Bristol-Myers Squibb Company
• Pacific World Corporation
• Valeant Pharmaceuticals International
• Revitol Corporation
• Avita Medical Limited

Keloid Treatment Market Insights

Lucintel forecasts that intralesional corticosteroid injections is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Features of the Global Keloid Treatment Market

Market Size Estimates: Keloid treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Keloid treatment market size by treatment, end use industry, and region in terms of value ($B).

Regional Analysis: Keloid treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different treatment, end use industry, and regions for the keloid treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the keloid treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the keloid treatment market size?

Answer: The global keloid treatment market is expected to reach an estimated $4.43 billion by 2030.

Q.2 What is the growth forecast for keloid treatment market?

Answer: The global keloid treatment market is expected to grow with a CAGR of 3.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the keloid treatment market?

Answer: The major drivers for this market are rise in burn cases and auto accidents, developments in keloid treatment methods, and growing acceptance of cosmetic surgery.

Q4. What are the major segments for keloid treatment market?

Answer: The future of the keloid treatment market looks promising with opportunities in the hospitals, dermatology clinics, and ambulatory surgical centers (ASCS) markets.

Q5. Who are the key keloid treatment market companies?

Answer: Some of the key keloid treatment companies are as follows.

• Novartis
• Sensus Healthcare
• RXi Pharmaceuticals
• Sonoma Pharmaceuticals
• Perrigo Company
• Bristol-Myers Squibb Company
• Pacific World Corporation
• Valeant Pharmaceuticals International
• Revitol Corporation
• Avita Medical Limited

Q6. Which keloid treatment market segment will be the largest in future?

Answer: Lucintel forecasts that intralesional corticosteroid injections is expected to witness highest growth over the forecast period.

Q7. In keloid treatment market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the keloid treatment market by treatment (occlusive dressing, compression therapy, cryosurgery,excision, radiation therapy, laser therapy, interferon therapy, intralesional corticosteroid injections, and others, ), end use industry (hospitals, dermatology clinics, ambulatory surgical centers (ASCS), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Keloid Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Keloid Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Keloid Treatment Market by Treatment
  • 3.3.1: Occlusive Dressing
  • 3.3.2: Compression Therapy
  • 3.3.3: Cryosurgery
  • 3.3.4: Excision
  • 3.3.5: Radiation Therapy
  • 3.3.6: Laser Therapy
  • 3.3.7: Interferon Therapy
  • 3.3.8: Intralesional Corticosteroid Injections
  • 3.3.9: Others
• 3.4: Global Keloid Treatment Market by End Use Industry
  • 3.4.1: Hospitals
  • 3.4.2: Dermatology Clinics
  • 3.4.3: Ambulatory Surgical Centers (ASCs)
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Keloid Treatment Market by Region
• 4.2: North American Keloid Treatment Market
  • 4.2.2: North American Keloid Treatment Market by End Use Industry: Hospitals, Dermatology Clinics, Ambulatory Surgical Centers (ASCs), and Others
• 4.3: European Keloid Treatment Market
  • 4.3.1: European Keloid Treatment Market by Treatment: Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injections, and Others
  • 4.3.2: European Keloid Treatment Market by End Use Industry: Hospitals, Dermatology Clinics, Ambulatory Surgical Centers (ASCs), and Others
• 4.4: APAC Keloid Treatment Market
  • 4.4.1: APAC Keloid Treatment Market by Treatment: Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injections, and Others
  • 4.4.2: APAC Keloid Treatment Market by End Use Industry: Hospitals, Dermatology Clinics, Ambulatory Surgical Centers (ASCs), and Others
• 4.5: ROW Keloid Treatment Market
  • 4.5.1: ROW Keloid Treatment Market by Treatment: Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Radiation Therapy, Laser Therapy, Interferon Therapy, Intralesional Corticosteroid Injections, and Others
  • 4.5.2: ROW Keloid Treatment Market by End Use Industry: Hospitals, Dermatology Clinics, Ambulatory Surgical Centers (ASCs), and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Keloid Treatment Market by Treatment
  • 6.1.2: Growth Opportunities for the Global Keloid Treatment Market by End Use Industry
  • 6.1.3: Growth Opportunities for the Global Keloid Treatment Market by Region
• 6.2: Emerging Trends in the Global Keloid Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Keloid Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Keloid Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Novartis
• 7.2: Sensus Healthcare
• 7.3: RXi Pharmaceuticals
• 7.4: Sonoma Pharmaceuticals
• 7.5: Perrigo Company
• 7.6: Bristol-Myers Squibb Company
• 7.7: Pacific World Corporation
• 7.8: Valeant Pharmaceuticals International
• 7.9: Revitol Corporation
• 7.10: Avita Medical Limited